glp 1 agonists adverse effects GI of Glucagon-Like Peptide-1 Receptor Long-term Success of GLP-1s Hinges

10.3390/ph17060736 2 AhmannA

Rode, A

However, evidence specifically addressing their use in SIH and SID remains limited, underscoring the need for focussed investigation in this patient population

There were also more frequent arrhythmias requiring anti-arrhythmic agents in the control group [50]

doi: 10.1210/clinem/dgab722

In addition, the GLP-1 can inhibit postprandial gastric emptying and reduce gastric acid secretion, inhibit gastric and duodenal peristalsis by inhibiting vagus nerve, and increase the pressure of pylorus, thus reducing appetite, causing a reduction in body weight and participating in the so-called ileal braking effect (19, 35)